Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20921 | 441 | 47.3 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
422 | 3 | C REACTIVE PROTEIN//STAT3//HAPTOGLOBIN | 28303 |
1852 | 2 | INTERLEUKIN 1//INTERLEUKIN 1 RECEPTOR ANTAGONIST//POLYMORPHISM | 6090 |
20921 | 1 | BASAL CELL CARCINOMA CELLS//NIJMEGEN MOL LIFE SCI 278//SILTUXIMAB | 441 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BASAL CELL CARCINOMA CELLS | authKW | 138480 | 0% | 100% | 2 |
2 | NIJMEGEN MOL LIFE SCI 278 | address | 138480 | 0% | 100% | 2 |
3 | SILTUXIMAB | authKW | 99697 | 1% | 24% | 6 |
4 | HUMAN OVARIAN TISSUES | authKW | 92319 | 0% | 67% | 2 |
5 | UNIT HUMAN TUMOR IMMUNOBIOL | address | 92319 | 0% | 67% | 2 |
6 | ALPHA PAK | authKW | 69240 | 0% | 100% | 1 |
7 | APOPTOSIS INDUCTORS | authKW | 69240 | 0% | 100% | 1 |
8 | AS IL6 | authKW | 69240 | 0% | 100% | 1 |
9 | ASCITES AND METASTASIS | authKW | 69240 | 0% | 100% | 1 |
10 | ASCITIC FLUID T LYMPHOCYTE | authKW | 69240 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 4680 | 53% | 0% | 234 |
2 | Cell Biology | 510 | 19% | 0% | 83 |
3 | Urology & Nephrology | 292 | 8% | 0% | 36 |
4 | Immunology | 189 | 12% | 0% | 51 |
5 | Biochemistry & Molecular Biology | 110 | 17% | 0% | 76 |
6 | Endocrinology & Metabolism | 85 | 7% | 0% | 29 |
7 | Medicine, Research & Experimental | 78 | 6% | 0% | 27 |
8 | Obstetrics & Gynecology | 59 | 4% | 0% | 19 |
9 | Pathology | 34 | 3% | 0% | 14 |
10 | Genetics & Heredity | 11 | 4% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NIJMEGEN MOL LIFE SCI 278 | 138480 | 0% | 100% | 2 |
2 | UNIT HUMAN TUMOR IMMUNOBIOL | 92319 | 0% | 67% | 2 |
3 | BIDMC GENOMICS | 69240 | 0% | 100% | 1 |
4 | BIOCHEM MOL BIOL ANAT | 69240 | 0% | 100% | 1 |
5 | CANC BIOSTAT BIOSTAT | 69240 | 0% | 100% | 1 |
6 | CANC DEV NIH | 69240 | 0% | 100% | 1 |
7 | CANC INFLAMMAT CANC | 69240 | 0% | 100% | 1 |
8 | CATTEDRA ONCOL MED INTERNAL MED ALLERGY CLIN | 69240 | 0% | 100% | 1 |
9 | CESI GD ANNUNZIO | 69240 | 0% | 100% | 1 |
10 | CHRISTIE HOSP MED ONCOL | 69240 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROSTATE | 6078 | 5% | 0% | 20 |
2 | CYTOKINE | 3509 | 3% | 0% | 15 |
3 | EUROPEAN CYTOKINE NETWORK | 3438 | 2% | 1% | 7 |
4 | CLINICAL CANCER RESEARCH | 1029 | 3% | 0% | 15 |
5 | CANCER RESEARCH | 992 | 5% | 0% | 24 |
6 | ANTICANCER RESEARCH | 795 | 3% | 0% | 15 |
7 | CYTOKINE & GROWTH FACTOR REVIEWS | 773 | 1% | 0% | 3 |
8 | IDRUGS | 739 | 0% | 1% | 2 |
9 | NEOPLASIA | 651 | 1% | 0% | 4 |
10 | CANCER LETTERS | 557 | 2% | 0% | 10 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NGUYEN, DP , LI, JY , TEWARI, AK , (2014) INFLAMMATION AND PROSTATE CANCER: THE ROLE OF INTERLEUKIN 6 (IL-6).BJU INTERNATIONAL. VOL. 113. ISSUE 6. P. 986-992 | 26 | 48% | 28 |
2 | GUO, YQ , XU, F , LU, TJ , DUAN, ZF , ZHANG, Z , (2012) INTERLEUKIN-6 SIGNALING PATHWAY IN TARGETED THERAPY FOR CANCER.CANCER TREATMENT REVIEWS. VOL. 38. ISSUE 7. P. 904 -910 | 32 | 29% | 179 |
3 | WANG, Y , LI, LZ , GUO, XQ , JIN, X , SUN, WJ , ZHANG, XL , XU, RC , (2012) INTERLEUKIN-6 SIGNALING REGULATES ANCHORAGE-INDEPENDENT GROWTH, PROLIFERATION, ADHESION AND INVASION IN HUMAN OVARIAN CANCER CELLS.CYTOKINE. VOL. 59. ISSUE 2. P. 228-236 | 23 | 52% | 39 |
4 | MASOUMI-MOGHADDAM, S , AMINI, A , WEI, AQ , ROBERTSON, G , MORRIS, DL , (2015) INTRATUMORAL INTERLEUKIN-6 PREDICTS ASCITES FORMATION IN PATIENTS WITH EPITHELIAL OVARIAN CANCER: A POTENTIAL TOOL FOR CLOSE MONITORING.JOURNAL OF OVARIAN RESEARCH. VOL. 8. ISSUE . P. - | 19 | 63% | 0 |
5 | YU, SH , ZHENG, QZ , ESOPI, D , MACGREGOR-DAS, A , LUO, J , ANTONARAKIS, ES , DRAKE, CG , VESSELLA, R , MORRISSEY, C , DE MARZO, AM , ET AL (2015) A PARACRINE ROLE FOR IL6 IN PROSTATE CANCER PATIENTS: LACK OF PRODUCTION BY PRIMARY OR METASTATIC TUMOR CELLS.CANCER IMMUNOLOGY RESEARCH. VOL. 3. ISSUE 10. P. 1175 -1184 | 16 | 50% | 4 |
6 | CULIG, Z , STEINER, H , BARTSCH, G , HOBISCH, A , (2005) INTERIEUKIN-6 REGULATION OF PROSTATE CANCER CELL GROWTH.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. 95. ISSUE 3. P. 497-505 | 24 | 33% | 174 |
7 | SAKAI, I , MIYAKE, H , TERAKAWA, T , FUJISAWA, M , (2011) INHIBITION OF TUMOR GROWTH AND SENSITIZATION TO CHEMOTHERAPY BY RNA INTERFERENCE TARGETING INTERLEUKIN-6 IN THE ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER PC3 MODEL.CANCER SCIENCE. VOL. 102. ISSUE 4. P. 769 -775 | 19 | 43% | 11 |
8 | LANE, D , MATTE, I , RANCOURT, C , PICHE, A , (2011) PROGNOSTIC SIGNIFICANCE OF IL-6 AND IL-8 ASCITES LEVELS IN OVARIAN CANCER PATIENTS.BMC CANCER. VOL. 11. ISSUE . P. - | 17 | 44% | 40 |
9 | GU, L , TALATI, P , VOGIATZI, P , ROMERO-WEAVER, AL , ABDULGHANI, J , LIAO, ZY , LEIBY, B , HOANG, DT , MIRTTI, T , ALANEN, K , ET AL (2014) PHARMACOLOGIC SUPPRESSION OF JAK1/2 BY JAK1/2 INHIBITOR AZD1480 POTENTLY INHIBITS IL-6-INDUCED EXPERIMENTAL PROSTATE CANCER METASTASES FORMATION.MOLECULAR CANCER THERAPEUTICS. VOL. 13. ISSUE 5. P. 1246-1258 | 19 | 39% | 8 |
10 | BEN JEMAA, A , BOURAOUI, Y , BEN RAIS, N , NOUIRA, Y , OUESLATI, R , (2016) CYTOKINE PROFILING IDENTIFIES AN INTERACTION OF IL-6 AND IL-1 ALPHA TO DRIVE PSMA-PSA PROSTATE CLONES.IMMUNOBIOLOGY. VOL. 221. ISSUE 12. P. 1424 -1431 | 17 | 43% | 0 |
Classes with closest relation at Level 1 |